Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
Home
Poster Schedule
All Days
Mon, Aug 26
Tue, Aug 27
Wed, Aug 28
Poster Schedule
Type here to filter the list
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(001) Advancements in Rheumatoid Arthritis Management: An Analysis of Clinical Features and Treatment Outcomes in a Brazilian Cohort
Favorite
8:00 AM – 6:00 PM
CEST
(002) Assessment of medication adherence and its factors influencing poor medication adherence among psoriasis patients: a cross-sectional study
Favorite
8:00 AM – 6:00 PM
CEST
(003) Assessment of medication adherence and the impact of clinical pharmacist interventions on medication adherence among systemic lupus erythematosus patients: a prospective cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(004) Clinical and Economic Burden of Polymyalgia Rheumatica in Patients with an Inadequate Response to Glucocorticoids or Glucocorticoids Taper in a Real-World Setting
Favorite
8:00 AM – 6:00 PM
CEST
(005) Cohort studies on 71 different adverse health outcomes among people with atopic eczema in UK primary care data
Favorite
8:00 AM – 6:00 PM
CEST
(006) Determination of patients’ quality of life (QOL) and its influencing risk factors associated with QOL in patients with autoimmune systemic vasculitis: a cross-sectional study
Favorite
8:00 AM – 6:00 PM
CEST
(007) Determining lines of therapy in real world patients with rheumatoid arthritis: analyses of a nationwide claims database in Japan
Favorite
8:00 AM – 6:00 PM
CEST
(008) Disease Activity in Rheumatoid Arthritis Patients Initiating Anti-Obesity Medication in a Longitudinal US-Based Real-World Cohort
Favorite
8:00 AM – 6:00 PM
CEST
(009) Drug survival and safety of biosimilars compared with originator adalimumab for Psoriasis: a multinational cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(010) Drug Survival of Baricitinib in Treatment-Naïve Patients with Rheumatoid Arthritis (RA): a population-based study
Favorite
8:00 AM – 6:00 PM
CEST
(011) Enhanced Pharmacovigilance to Contextualize 13 years of Monitoring: The Gilenya Pregnancy Registry put in Perspective with the Fingolimod PRegnancy outcomes Intensive Monitoring (PRIM) Program
Favorite
8:00 AM – 6:00 PM
CEST
(012) Ensuring Safety: A Comprehensive Review of the Subcutaneous Administration of Biologics
Favorite
8:00 AM – 6:00 PM
CEST
(013) Epidemiology and Disease Burden of Generalized Pustular Psoriasis – A Retrospective Cohort Study in Finland
Favorite
8:00 AM – 6:00 PM
CEST
(014) Establish a Prediction Model for Treatment Response of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Favorite
8:00 AM – 6:00 PM
CEST
(015) Estimating Prevalence of Moderate-to-Severe Systemic Lupus Erythematosus. A Literature Review
Favorite
8:00 AM – 6:00 PM
CEST
(016) Hormone Therapy and Risk of Psoriasis in Reproductive and Postmenopausal Women: A Nationwide Cohort Study in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(017) Immune Checkpoint Inhibitors and Overlap Syndrome of Myocarditis and Myositis or Myasthenia Gravis: Analysis of WHO VigiBase Database.
Favorite
8:00 AM – 6:00 PM
CEST
(018) Impact of Immune Checkpoint Inhibitors on Psoriasis Incidence: Emulation of a Randomized Target Trial Using Real-world Data
Favorite
8:00 AM – 6:00 PM
CEST
(019) Initial and subsequent biological therapies for patients with psoriasis vulgaris during 2010-2021 in Japan
Favorite
8:00 AM – 6:00 PM
CEST
(020) Initiation Trends of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Adults in the United States from 2001 to 2021
Favorite
8:00 AM – 6:00 PM
CEST
(021) Line of Therapy of Biologics and JAK Inhibitors in RA, PsA, and AxSpA: Implications for Design and Uptake of New Drugs and Diagnostics
Favorite
8:00 AM – 6:00 PM
CEST
(022) Market Uptake and Pattern of Use of Emerging Topical Rosacea Medications in Switzerland: a Descriptive Study using Swiss Claims Data
Favorite
8:00 AM – 6:00 PM
CEST
(023) Medication persistence in the treatment of rheumatoid arthritis in the Brazilian Public Health System
Favorite
8:00 AM – 6:00 PM
CEST
(024) Mortality in an Eosinophilic Granulomatosis with Polyangiitis (EGPA) Incident Cohort: A Retrospective Study in England
Favorite
8:00 AM – 6:00 PM
CEST
(025) Overall survival in immune checkpoint inhibitor-treated patients with rheumatoid arthritis and non-small cell lung cancer: a Medicare claims study
Favorite
8:00 AM – 6:00 PM
CEST
(026) Potential Drug Interaction in Janus Kinase Inhibitors Users Among Patients with Rheumatoid Arthritis or Psoriatic arthritis in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(027) Prescribing Patterns of Biological Therapies in Psoriasis Management: A Retrospective Cohort Study in Saudi Arabia
Favorite
8:00 AM – 6:00 PM
CEST
(028) Prescription Patterns After the Approval of Dupilumab, Abrocitinib, Baricitinib, and Upadacitinib in Adults with Atopic Dermatitis: A Real-World Evidence from a Multi-Institutional Database in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(029) Prevalence of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®
Favorite
8:00 AM – 6:00 PM
CEST
(030) Prevalence, characteristics, and prescription pain medication use in the rheumatoid arthritis population
Favorite
8:00 AM – 6:00 PM
CEST
(031) Real-World Patterns in Treatment Switching to Biosimilar Adalimumab in the United States
Favorite
8:00 AM – 6:00 PM
CEST
(032) Real-World Utilization Patterns of Immune Checkpoint Inhibitors: based on the National Health Insurance Service Data in Korea (2017-2022)
Favorite
8:00 AM – 6:00 PM
CEST
(033) Risk of hypertension and type 2 diabetes in patients with systemic lupus erythematous: A retrospective cohort study in Yinzhou, China
Favorite
8:00 AM – 6:00 PM
CEST
(034) Risk of safety outcomes associated with the long-term use of oral corticosteroids: A nested case-control study of 1 million patients with atopic dermatitis
Favorite
8:00 AM – 6:00 PM
CEST
(035) Safety Events in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis Exposed to Tofacitinib (Xeljanz) or Biologics: Real-World Data from the CARRA Registry
Favorite
8:00 AM – 6:00 PM
CEST
(036) Serious Infection Risk Associated With Biologics and Systemic Nonbiologics in Patients With Psoriasis: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
Favorite
8:00 AM – 6:00 PM
CEST
(037) Switching proportion assessment in rheumatoid arthritis patients exposed to disease modifying anti-rheumatic drugs: systematic review and meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(038) Treatment of rheumatoid arthritis in the Brazilian Public Health System: medication use profile
Favorite
8:00 AM – 6:00 PM
CEST
(039) Treatment Patterns in Moderate to Severe Psoriasis: A Hospital-based Retrospective Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(040) Trends in Management of Inflammatory Bowel Disease in Sweden and Norway, 1982-2016
Favorite
8:00 AM – 6:00 PM
CEST
(041) Use of Digital Health Tools to Evaluate Change in Clinical and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis Initiating Treatment with a JAKi or TNFi
Favorite
8:00 AM – 6:00 PM
CEST
(042) Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis
Favorite
8:00 AM – 6:00 PM
CEST
(043) Utilization of newly approved targeted immunomodulating treatments for atopic dermatitis
Favorite
8:00 AM – 6:00 PM
CEST
(044) Utilizing Real-World Data to Create an External Control Arm for a Phase 3 Trial of Deucravacitinib for Treatment of Plaque Psoriasis
Favorite
8:00 AM – 6:00 PM
CEST
(045) Vitiligo Disease Severity and Real-World Treatment Patterns
Favorite
8:00 AM – 6:00 PM
CEST
(046) Adverse Effects of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Patients with Chronic Myeloid Leukemia
Favorite
8:00 AM – 6:00 PM
CEST
(047) Anaphylaxis Risk and Long-Term Central Venous Catheter Use: a Health Plan Claims Database Analysis Comparing Subcutaneous and Intravenous Pertuzumab / Trastuzumab Administration in the US
Favorite
8:00 AM – 6:00 PM
CEST
(048) Antiangiogenic Drugs and the Risk of Arterial Dissection or Aneurysm in Patients with Metastatic Colorectal Cancer
Favorite
8:00 AM – 6:00 PM
CEST
(049) Assess the applicability of capmatinib and tepotinib to real-world patients in Taiwan with MET mutations
Favorite
8:00 AM – 6:00 PM
CEST
(050) Association Between Aromatase Inhibitors and Dry Eye Disease Among Women with Breast Cancer
Favorite
8:00 AM – 6:00 PM
CEST
(051) Assessment of Risk-Benefit Balance of Immune Checkpoint Inhibitors in a Real-World Lung Cancer Population
Favorite
8:00 AM – 6:00 PM
CEST
(052) Clinical Responses to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Patient Characteristics and Predictors
Favorite
8:00 AM – 6:00 PM
CEST
(053) Comparative Analysis on incident risk of Anemia and Immune-Mediated Hepatitis in non-small cell lung cancer (NSCLC): Enhancing Cross-Data Source Comparability in PD-1/PD-L1 Therapy
Favorite
8:00 AM – 6:00 PM
CEST
(054) Computational Drug Repurposing for gallbladder cancer integrated with pharmacovigilance approach
Favorite
8:00 AM – 6:00 PM
CEST
(055) Development and portability of a text mining algorithm for capturing disease progression in electronic health records of with stage IV non-small cell lung cancer treated with immuno-chemotherapy
Favorite
8:00 AM – 6:00 PM
CEST
(056) Examination of treatment patterns amongst drug classes in metastatic non-small cell lung cancer patients across EU4, UK, and US
Favorite
8:00 AM – 6:00 PM
CEST
(058) First-line therapy discontinuation among Brazilian multiple myeloma patients: incidence and reasons
Favorite
8:00 AM – 6:00 PM
CEST
(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(060) Genomic profiling and the need for immunotherapy in gastric cancer
Favorite
8:00 AM – 6:00 PM
CEST
(061) Healthcare Utilization among Cancer Patients Treated with Immune Checkpoint Inhibitors in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(062) Identifying Adverse Drug Reactions Through Knowledge Graph Modeling
Favorite
8:00 AM – 6:00 PM
CEST
(063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
Favorite
8:00 AM – 6:00 PM
CEST
(064) Incidence and risk of secondary myelodysplastic syndrome and acute myeloid leukaemia in ovarian cancer patients treated with poly-ADP ribose polymerase inhibitors in England
Favorite
8:00 AM – 6:00 PM
CEST
(065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
Favorite
8:00 AM – 6:00 PM
CEST
(066) Incidence of Infections in Clinical Trials of Treatments for Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(068) Investigating the Effect of Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Radiotherapy-related Toxicities and Treatment Outcome in Patients with Cancer: A Systematic Review and Meta-Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(069) Isatuximab Adverse Event Monitoring: A Safety Meta-Analysis of Randomized Controlled Trials and Refining Signals through Pharmacovigilance Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(070) NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
Favorite
8:00 AM – 6:00 PM
CEST
(071) Ocular adverse events associated with platins: A disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports
Favorite
8:00 AM – 6:00 PM
CEST
(072) Patterns of Underreporting of Enrollment Dates in Cancer Clinical Trials: A HemOnc Knowledgebase Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(073) Pharmacometaboomics suggest a causal link between an excipient in cyclosporine A capsules and incomplete mycophenolate mofetil prodrug activation in kidney transplant recipients
Favorite
8:00 AM – 6:00 PM
CEST
(074) Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in Advanced Non-Small Cell Lung Cancer (aNSCLC): Analysis of Patient-Level Pooled Randomized Clinical Trials (RCTs)
Favorite
8:00 AM – 6:00 PM
CEST
(075) Real-World Treatment of Patients with Chronic Lymphocytic Leukemia: Results from Analysis of US Health Insurance Claims Dataset
Favorite
8:00 AM – 6:00 PM
CEST
(076) Real-World utilization of 1L systemic therapy amongst Black and Non-Hispanic White patients with advanced or recurrent endometrial cancer
Favorite
8:00 AM – 6:00 PM
CEST
(077) Replication of overall response in mNSCLC patients treated with pembrolizumab and chemotherapy using RECIST 1.1 criteria applied to images from the real world
Favorite
8:00 AM – 6:00 PM
CEST
(078) Risk Evaluation of Vascular Adverse Events in Chronic Myeloid Leukemia Patients Following First-Line TKI Therapy Initiation
Favorite
8:00 AM – 6:00 PM
CEST
(079) Synthesized Learnings and Considerations from Global Historical Cohort Studies via Retrospective Chart Review in Oncology
Favorite
8:00 AM – 6:00 PM
CEST
(080) The treatment modalities and radiotherapy pattern in patients of primary lung cancer with distant metastasis in Japan
Favorite
8:00 AM – 6:00 PM
CEST
(081) The use of opioid and non-opioid analgesics and illicit drugs among patients with cancer in the U.S.: prevalence and association with mortality
Favorite
8:00 AM – 6:00 PM
CEST
(082) Use of Systemic and Topical Glucocorticoids and Risk of Skin Cancers in a Prospective Cohort of French Women.
Favorite
8:00 AM – 6:00 PM
CEST
(083) Utility of Digitally-Enabled Tools in Community Education and Activation for LDCT screening for Lung Cancer
Favorite
8:00 AM – 6:00 PM
CEST
(084) A Cohort Study to Evaluate the Real-World Utilization and Effectiveness of Bebtelovimab Compared to Nirmatrelvir/Ritonavir among Patients with Mild-to-Moderate COVID-19 Who Are at High Risk for Progressing to Severe Illness
Favorite
8:00 AM – 6:00 PM
CEST
(085) Alterations in Influenza Management - the Potential Influence of the COVID-19 Pandemic
Favorite
8:00 AM – 6:00 PM
CEST
(086) Assessing the Robustness of Comparative Effectiveness Studies: An Applied Example Evaluating the Effectiveness of Bebtelovimab In COVID-19
Favorite
8:00 AM – 6:00 PM
CEST
(087) Association of Substance Use Disorder and Risk of COVID-19-related Outcomes Among Adults in Hong Kong
Favorite
8:00 AM – 6:00 PM
CEST
(088) Capturing Information Not Presented in Hazard Ratios: The Added Value of Presenting Plots of Instantaneous Hazards for Time-To-Event Analyses
Favorite
8:00 AM – 6:00 PM
CEST
(089) Characterisation of ICNARC COVID-19 data
Favorite
8:00 AM – 6:00 PM
CEST
(090) Characteristics of Registered Clinical Trials Investigating Therapeutic Interventions for Long COVID
Favorite
8:00 AM – 6:00 PM
CEST
(091) Characterization of select laboratory test in administrative healthcare data and data from commercial laboratories among patients with COVID-19 diagnosed in outpatient settings
Favorite
8:00 AM – 6:00 PM
CEST
(092) Characterizing Post-COVID Muscle Weakness Using Structured and Unstructured Electronic Health Records
Favorite
8:00 AM – 6:00 PM
CEST
(093) Cohort event monitoring of COVID-19 vaccine safety using patient-reported outcomes in lactating women.
Favorite
8:00 AM – 6:00 PM
CEST
(094) Concomitant prescribing of nirmatrelvir/ritonavir (NMV-r) and medications with potential risk for drug-drug interaction – a feasibility assessment of Truveta Electronic Health Records Database.
Favorite
8:00 AM – 6:00 PM
CEST
(095) COVID-19 Lockdown and the Osteoporosis Treatment Among US Medicare Enrollees Who Initiated Romosozumab
Favorite
8:00 AM – 6:00 PM
CEST
(096) COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An Interrupted Time-Series Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(097) COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
Favorite
8:00 AM – 6:00 PM
CEST
(098) Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults: A Retrospective Inception Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(099) Distinguishing Hospital Encounters as "with" vs "for" COVID-19 Using A Large US Administrative Claims Database
Favorite
8:00 AM – 6:00 PM
CEST
(100) Drug Shortages in the U.S. and Canada Prior to and During the COVID-19 Pandemic: A Multi-National, Cross-Sectional Study
Favorite
8:00 AM – 6:00 PM
CEST
(101) Effectiveness of pre-pregnancy maternal SARS-CoV-2 vaccination in preventing COVID-19 in infants
Favorite
8:00 AM – 6:00 PM
CEST
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(103) Evaluation of Two Methods in Minimizing Confounding by Indication Bias in Observational Research: an Example Based on Guideline-recommended COVID-19 therapies
Favorite
8:00 AM – 6:00 PM
CEST
(104) Healthcare Utilization Among People Living With Long COVID 2.5 Years After Acute COVID-19
Favorite
8:00 AM – 6:00 PM
CEST
(105) Hospital-level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(106) Impact of allergic conditions on COVID-19 susceptibility and outcomes
Favorite
8:00 AM – 6:00 PM
CEST
(107) Impact of the COVID-19 pandemic and control measures on screening and diagnoses of type 2 diabetes in British Columbia
Favorite
8:00 AM – 6:00 PM
CEST
(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data
Favorite
8:00 AM – 6:00 PM
CEST
(109) Incidence Rate of Long COVID Among Overweight or Obese Adults Who Had COVID-19 Infection in the United Kingdom
Favorite
8:00 AM – 6:00 PM
CEST
(110) Influenza and SARS-CoV-2 coinfection: A Rapid Review of Epidemiological Literature 2020-2023
Favorite
8:00 AM – 6:00 PM
CEST
(111) Inhaled corticosteroid use associated with severity of COVID-19 diagnosis among patients with asthma, a cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(112) Investigating Previous Antibiotic Exposure Patterns among COVID-19 Hospitalised Patients: An OpenSAFELY Matched Case-Control Study
Favorite
8:00 AM – 6:00 PM
CEST
(113) Investigation of the Consumption Trend of Inhalants Used in the Treatment of Obstructive Airway Diseases During the COVID-19 Pandemic
Favorite
8:00 AM – 6:00 PM
CEST
(114) New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program
Favorite
8:00 AM – 6:00 PM
CEST
(115) Nirmatrelvir and Ritonavir (Paxlovid) Prognostication: Unveiling Utilization Trends with Neural Network Time Series Forecasting
Favorite
8:00 AM – 6:00 PM
CEST
(116) Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe Covid-19: An Analysis of the National Covid Cohort Collaborative (N3C)
Favorite
8:00 AM – 6:00 PM
CEST
(117) Outcomes in patients hospitalized with severe COVID-19 treated with add-on immunomodulatory agents
Favorite
8:00 AM – 6:00 PM
CEST
(118) Patient factors associated with effectiveness of nirmatrelvir and ritonavir in prevention of Covid-19 hospitalization or death
Favorite
8:00 AM – 6:00 PM
CEST
(119) Performance of the US Food and Drug Administration’s COVID-19 Disease Severity Categorization for Use in Real-World Data
Favorite
8:00 AM – 6:00 PM
CEST
(120) Post-COVID Conditions: Prevalence and Associated Factors in Individuals with Intellectual Disabilities in Sweden
Favorite
8:00 AM – 6:00 PM
CEST
(121) Potential for Differential Outcome Misclassification in United States Claims Data during the COVID-19 Era: An Applied Example
Favorite
8:00 AM – 6:00 PM
CEST
(122) Prenatal-, Birth- and Post-Partum- Related Experiences among Women who were Pregnant in First Three Waves of the COVID-19 Pandemic in Canada: a Study Within the CONCEPTION Cohort.
Favorite
8:00 AM – 6:00 PM
CEST
(123) Racial and language disparities in initial COVID-19 vaccination during lactation
Favorite
8:00 AM – 6:00 PM
CEST
(124) Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation
Favorite
8:00 AM – 6:00 PM
CEST
(125) Reproducibility of computable phenotypes for post-acute sequelae of COVID-19 (PASC) in US administrative claims data
Favorite
8:00 AM – 6:00 PM
CEST
(126) Risk Factors for Long-Term Cardiovascular Post-Acute Sequelae of COVID-19 Infection: a Nested Case-Control Study
Favorite
8:00 AM – 6:00 PM
CEST
(127) Risk factors for severe outcomes among patients hospitalized with COVID-19 in US Medicare between December 2020 and March 2023
Favorite
8:00 AM – 6:00 PM
CEST
(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea
Favorite
8:00 AM – 6:00 PM
CEST
(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(130) School Closures and Prescription Medication Use Among Children and Adolescents Before and During the COVID-19 Pandemic in the United States, 2019-2022
Favorite
8:00 AM – 6:00 PM
CEST
(131) Survival of critically ill COVID-19 patients in Sweden during the first two-and-a-half years of the pandemic
Favorite
8:00 AM – 6:00 PM
CEST
(132) The Association Between Asthma and Outcomes of COVID-19
Favorite
8:00 AM – 6:00 PM
CEST
(133) The Comparative Effectiveness of Baricitinib And Tocilizumab in Hospitalized Patients With Covid: A Retrospective Cohort Study of The National Covid Cohort Collaborative (N3C)
Favorite
8:00 AM – 6:00 PM
CEST
(134) The Impact of COVID-19 Containment Strictness on the Administration of Romosozumab among Medicare Enrollees in the Most Socioeconomically Vulnerable Counties in the US
Favorite
8:00 AM – 6:00 PM
CEST
(135) The Impact of COVID-19 Pandemic on Alcohol Dependence Treatment in Portugal: a Retrospective Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(136) The Impact of COVID-19 Pandemic on the Consumption of Anti-hypertensive, Anti-diabetes and Anti-hyperlipidemic Medications.
Favorite
8:00 AM – 6:00 PM
CEST
(137) The impact of prenatal maternal depression during the COVID-19 pandemic on maternal postpartum depression: A prospective cohort study within the CONCEPTION study.
Favorite
8:00 AM – 6:00 PM
CEST
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Favorite
8:00 AM – 6:00 PM
CEST
(139) Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic
Favorite
8:00 AM – 6:00 PM
CEST
(140) Use of Ursodeoxycholic Acid and the Risk of Long COVID in Patients with Steatotic Liver Disease
Favorite
8:00 AM – 6:00 PM
CEST
(141) A Cross-Sectional Observational Study to Assess Treatment Awareness, Prescription Pattern and Adverse Drug Reactions of Secondary Prophylactic Drug Treatment in Patients of Stroke visiting a Tertiary Care Hospital.
Favorite
8:00 AM – 6:00 PM
CEST
(142) A multi-country, observational study of high-risk pre-event cardiovascular patients: design and analytical framework
Favorite
8:00 AM – 6:00 PM
CEST
(143) A Population-Based Assessment of the Use of Oral Anticoagulants and the Risk of Major Bleeding Among Patients with Non-Valvular Atrial Fibrillation Treated With Antiarrhythmics
Favorite
8:00 AM – 6:00 PM
CEST
(144) A scoping Review of Factors Associated with the Prescribing of Direct Oral Anticoagulant Drugs (DOACs)
Favorite
8:00 AM – 6:00 PM
CEST
(145) Acute cardiovascular adverse effects associated with the use of prescription medications: A Danish nationwide screening study
Favorite
8:00 AM – 6:00 PM
CEST
(146) An Electronic Health Record Analysis Studying Differences in Medication Use Associated with Renal Impairment in Acute Heart Failure
Favorite
8:00 AM – 6:00 PM
CEST
(147) Antiplatelet Drug Utilization Trends in Hungary from 2012 to 2022
Favorite
8:00 AM – 6:00 PM
CEST
(148) Association between incident interstitial lung disease with direct oral anticoagulants compared to warfarin users: Multi-database cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(149) Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica
Favorite
8:00 AM – 6:00 PM
CEST
(150) Associations between β-adrenoreceptors agonists and antagonists and Parkinson’s disease: systematic review and meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(151) Case Study With a Cardiovascular Outcomes Trial for a Glucagon-Like Peptide-1 Receptor Agonist: Evaluating Trial Generalizability With an Enriched Electronic Health Record-Based Database
Favorite
8:00 AM – 6:00 PM
CEST
(152) Characterizing Patients with Postural Orthostatic Tachycardia Syndrome (POTS) in Claims Data After the Introduction of a Specific Diagnosis Code
Favorite
8:00 AM – 6:00 PM
CEST
(154) Comparative cardiovascular safety evaluation of long- vs short-acting erythropoiesis-stimulating agents (ESA) in chronic kidney disease patients: a meta-analysis and signal detection using the FDA Adverse Event Reporting System
Favorite
8:00 AM – 6:00 PM
CEST
(155) Comparative effectiveness and prescribing trends of modified-release versus immediate-release indapamide in patients with hypertension: a cohort study in the UK
Favorite
8:00 AM – 6:00 PM
CEST
(156) Comparative Effectiveness and Safety of High-Intensity Statin Monotherapy vs. Combination Therapy with Ezetimibe in Post-ACS Lipid Management in Asian Patients: An Observational Cohort Study in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(157) Comparative effectiveness of anti-hyperlipidemic drugs monotherapy in primary prevention of cardiovascular disease
Favorite
8:00 AM – 6:00 PM
CEST
(158) Comparative Effectiveness of ARB and ACEi for Cardiovascular Outcomes and Risk of Angioedema by Ethnicity: an Analysis in the UK Clinical Practice Research Datalink with Emulation of a Reference Trial (ONTARGET)
Favorite
8:00 AM – 6:00 PM
CEST
(159) Comparison of rates of myocardial infarction and stroke for patients with type 2 diabetes 2005 versus 2015
Favorite
8:00 AM – 6:00 PM
CEST
(160) Cost-Effectiveness of Statins in the Primary Prevention of Cardiovascular Disease in Older Adults: A 5-Year Retrospective Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(161) DARWIN EU® - Real-World Evaluation of Pulmonary Arterial Hypertension Treatment and Outcomes in Europe
Favorite
8:00 AM – 6:00 PM
CEST
(162) Decreased Hazard of Potassium Lowering Drug Prescription Receipt Following Implementation of the 2021 CKD-EPI Creatinine GFR Equation
Favorite
8:00 AM – 6:00 PM
CEST
(163) Disseminated Intravascular Coagulation after idarucizumab or andexanet alfa: a disproportional analysis and case-by-case analysis of reports from the FAERS database
Favorite
8:00 AM – 6:00 PM
CEST
(164) Early identification of the association between rofecoxib and cardiovascular adverse events using real-world data from the UK: A case-control study
Favorite
8:00 AM – 6:00 PM
CEST
(165) Effectiveness of early versus delayed post-discharge sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure with type 2 diabetes: a population-based cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(166) Effectiveness, Safety, and Mortality of Cilostazol versus Clopidogrel in East Asian Patients with Ischemic Stroke and Transient Ischemic Attack
Favorite
8:00 AM – 6:00 PM
CEST
(167) Evaluating Algorithms for Sinus Node Dysfunction in US Health Insurance Claims Databases
Favorite
8:00 AM – 6:00 PM
CEST
(168) Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States
Favorite
8:00 AM – 6:00 PM
CEST
(169) Exploration of Reason Codes in Real World Cardiovascular System Short-term Disability Claims in the United States
Favorite
8:00 AM – 6:00 PM
CEST
(170) FACTOR XA INHIBITOR–RELATED MAJOR BLEEDING EVENTS IN THE NETHERLANDS
Favorite
8:00 AM – 6:00 PM
CEST
(171) Factors Associated with Reinitiation and Subsequent Discontinuation of Antiplatelet Medication in Patients with Peripheral Arterial Disease
Favorite
8:00 AM – 6:00 PM
CEST
(172) Feasibility Assessment of Hypertension among Patients with Diabetic Macular Edema using Real World Data
Favorite
8:00 AM – 6:00 PM
CEST
(173) Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data
Favorite
8:00 AM – 6:00 PM
CEST
(174) Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(175) Implementation and Evaluation of Medication Therapy Management in Patients with Hypertension
Favorite
8:00 AM – 6:00 PM
CEST
(176) Incidence of Heat-Related Illness in the United States: A Retrospective Cohort Study Using the PharMetrics® Plus for Academics Dataset, 2017-2022
Favorite
8:00 AM – 6:00 PM
CEST
(177) Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
Favorite
8:00 AM – 6:00 PM
CEST
(178) Lasso Logistic Regression and Cluster Analysis in Predicting Adherence and Drug Patterns among New Users of Monotherapy for Antihypertensive Drugs: a long-term inception cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(179) Low-density Lipoprotein Measurement During and After Hospitalization with Myocardial Infarction in Denmark from 2018 to 2021.
Favorite
8:00 AM – 6:00 PM
CEST
(180) Mapping of Knowledge, Attitude & Practice in Patients Toward Cardiovascular Disorders Attending Out-Patient Department of Cardiology in a Tertiary Care Hospital
Favorite
8:00 AM – 6:00 PM
CEST
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Favorite
8:00 AM – 6:00 PM
CEST
(182) Oral anticoagulant prescription trends and adherence among patients with atrial fibrillation and mitral stenosis in Hong Kong
Favorite
8:00 AM – 6:00 PM
CEST
(183) Outcomes of antiarrythmic drugs versus catheter ablation for treatment of atrial fibrillation in an elderly population
Favorite
8:00 AM – 6:00 PM
CEST
(184) Patterns and Determinants of Adherence to Medication Guideline in Myocardial Infarction (MI) Survivors: A Retrospective Cohort Study of 21,510 patients
Favorite
8:00 AM – 6:00 PM
CEST
(185) Predicting Findings of Two On-Going Phase IV Randomized Trials of Direct Oral Anticoagulants: An RCT-DUPLICATE Study.
Favorite
8:00 AM – 6:00 PM
CEST
(186) Real-World Patient Profiles and Lipid-Lowering Efficacy of PCSK9 Inhibitors
Favorite
8:00 AM – 6:00 PM
CEST
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Favorite
8:00 AM – 6:00 PM
CEST
(188) Renal outcomes of cyclooxygenase-2 inhibitor anti-inflammatories: a systematic review and meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(189) Risk identification based on prescribed drugs and comorbidities in patients with Torsade de pointes arrhythmia – a population-based Swedish cohort study.
Favorite
8:00 AM – 6:00 PM
CEST
(190) Risk of Lung Cancer With Concomitant Use of Angiotensin Converting Enzyme Inhibitors and Dipeptidyl Peptidase 4 Inhibitors: Population Based Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(191) Sex differences in dispensed cardiovascular medication in primary care
Favorite
8:00 AM – 6:00 PM
CEST
(192) Shifting Patterns in Statin Intensity During Post-Acute Coronary Syndrome Period: An Nationwide Observational Study in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(193) Temporal Trends In The Dispensing Of Anti-Hypertensive Medications In Ireland And The United Kingdom From 2017-2023
Favorite
8:00 AM – 6:00 PM
CEST
(194) The Impact of National Volume-Based Procurement Program Implementation on Medical Expenditures in China: A Population-based Study of 1.17 Million Hypertensive Patients
Favorite
8:00 AM – 6:00 PM
CEST
(195) The use of Gastroprotective Agents in Patients with Atrial Fibrillation Initiating Direct Oral Anticoagulants
Favorite
8:00 AM – 6:00 PM
CEST
(196) Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform
Favorite
8:00 AM – 6:00 PM
CEST
(197) Using negative control outcomes in trial emulation to assess the comparability of patients initiating proprotein convertase subtilisin/kexin type 9 inhibitor monoclonal antibodies following myocardial infarction
Favorite
8:00 AM – 6:00 PM
CEST
(198) Utilisation Patterns and Trends of Statins in Kuwait from 2012 to 2022: A Population-Based Study
Favorite
8:00 AM – 6:00 PM
CEST
(199) Analysis of New Molecular Entity Utilization Patterns using the Sentinel Distributed Database
Favorite
8:00 AM – 6:00 PM
CEST
(200) Developing a drug shortages predictive model using real-world Canadian drug utilization
Favorite
8:00 AM – 6:00 PM
CEST
(201) Drug Utilisation Study of Radium-223 Under Routine Clinical Practice (DIRECT) in Europe: A Post-authorisation Safety Study
Favorite
8:00 AM – 6:00 PM
CEST
(202) Fear of Missing Out: Drug Availability in Canada versus the USA
Favorite
8:00 AM – 6:00 PM
CEST
(203) Medicine utilisation studies in Australian individual-level dispensing data: A blinded, multi-centre replication experiment
Favorite
8:00 AM – 6:00 PM
CEST
(204) Off-label drug prescriptions in Latin America: a systematic review
Favorite
8:00 AM – 6:00 PM
CEST
(205) Osteoporosis treatment patterns in France: A Clustering Analysis of the SNDS PMO Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(206) Patient characteristics associated with Topical Calcineurin Inhibitor Discontinuation: A retrospective cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(207) Patterns and Associated Factors with Emergency Department Visit due to Drug Poisoning in Korea
Favorite
8:00 AM – 6:00 PM
CEST
(208) Pharmacovigilance Analysis of Immune-Related Adverse Effects to Uncover Repurposable Drugs for Hepatocellular Carcinoma
Favorite
8:00 AM – 6:00 PM
CEST
(209) Potentially drug-related emergency hospital admissions and their influence on patient's long-term medication. Analysis of administrative data from a Scottish Database.
Favorite
8:00 AM – 6:00 PM
CEST
(210) Prevalence and Predictors for potentially Adverse Drug Event-related Hospitalisations
Favorite
8:00 AM – 6:00 PM
CEST
(211) Prevalence of Medication-Related Risk Factors for Adverse Drug Reactions
Favorite
8:00 AM – 6:00 PM
CEST
(212) Regional variations in the use of thyroid stimulating hormone measurements and levothyroxine in Germany: a small area analysis based on claims data
Favorite
8:00 AM – 6:00 PM
CEST
(213) Temporal trend in the commercialization of selective cyclooxygenase-2 inhibitors in drugstores in Brazil from 2014 to 2021
Favorite
8:00 AM – 6:00 PM
CEST
(214) Treatment patterns in patients with dermatomyositis in the United Kingdom: a cohort study using the Clinical Practice Research Datalink
Favorite
8:00 AM – 6:00 PM
CEST
(215) Use of intravenous iron between 2004 and 2019 in Germany overall and in pregnant women
Favorite
8:00 AM – 6:00 PM
CEST
(216) Use of leukotriene receptor antagonists (LTRAs) among patients with asthma in the UK primary care
Favorite
8:00 AM – 6:00 PM
CEST
(217) 5-alpha Reductase Inhibitors and Effects on Auditory System in Taiwan
Favorite
8:00 AM – 6:00 PM
CEST
(218) Assessing Environmental Risks Associated with Contraceptives: A Multi-Scenario Approach
Favorite
8:00 AM – 6:00 PM
CEST
(219) What motivates patients with chronic musculoskeletal pain to use medical cannabis as a treatment strategy? Results from a questionnaire study.
Favorite
8:00 AM – 6:00 PM
CEST
(220) Common Mental Health Diagnoses Arising from or Coinciding with Menopausal Transition and Prescribing of SSRIs/SNRIs and Other Psychotropic Medications
Favorite
8:00 AM – 6:00 PM
CEST
(221) Levonorgestrel-releasing Intrauterine Systems And Copper Intrauterine Devices Utilization In France: Changes From The Last Decade
Favorite
8:00 AM – 6:00 PM
CEST
(222) Menopausal hormone therapy and colorectal cancer recurrence and mortality: a Danish population-based cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(223) Real World Retrospective Analysis of Short-term Disability Claims for Genitourinary System Conditions in the United States
Favorite
8:00 AM – 6:00 PM
CEST
(224) Study of utilization of oral contraceptive drugs & relevant perceptions of general population in Greece with the use of a questionnaire
Favorite
8:00 AM – 6:00 PM
CEST
(225) Unveiling the Impact of Spironolactone in Women with PCOS: Beyond Its Anti-androgen Properties - Insights from a Systematic Review and Meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(226) Use of progestogens and the risk of intracranial meningioma: a national case-control study
Favorite
8:00 AM – 6:00 PM
CEST
(227) A Comprehensive Analysis to Unravel Antimicrobial Usage Patterns on a Global Scale: Decoding A Decade (2013-2022)
Favorite
8:00 AM – 6:00 PM
CEST
(228) A Cross-Sectional Observational Study to Assess Prescription Pattern, Awareness of Parents regarding Disease and Use of Antimicrobial agents and Cost of treatment in Children Admitted in a Tertiary Care Hospital.
Favorite
8:00 AM – 6:00 PM
CEST
(229) A national point prevalence survey to assess surgical antibiotic prophylaxis duration and timing in obstetrics and gynaecological surgery in Kuwait
Favorite
8:00 AM – 6:00 PM
CEST
(230) A pragmatic randomized trial assessing the impact of peer comparison and therapeutic recommendations on antibiotic prescribing patterns of family physicians for uncomplicated lower urinary tract infections
Favorite
8:00 AM – 6:00 PM
CEST
(231) Adverse drug reactions due to antitubercular therapy in multidrug resistant tuberculosis in North east India
Favorite
8:00 AM – 6:00 PM
CEST
(232) Antibiotic Exposure of Pediatric Patients: Local Study from an Urgent Care Clinic
Favorite
8:00 AM – 6:00 PM
CEST
(233) Antibiotic use and risk of microscopic colitis in older adults: a nationwide self-controlled case series study
Favorite
8:00 AM – 6:00 PM
CEST
(234) Antiretroviral Initiation and Adherence between Transgender and Cisgender Medicaid Beneficiaries with HIV
Favorite
8:00 AM – 6:00 PM
CEST
(235) Antitubercular Therapy Associated Gut Microbiota Dysbiosis in Pulmonary Tuberculosis: A Computational Analysis from Open Datasets
Favorite
8:00 AM – 6:00 PM
CEST
(236) Assessing Antibiotic Prescribing Patterns in Private Outpatient Settings: A WHO AWaRe Classification Analysis in a Jeddah Polyclinic
Favorite
8:00 AM – 6:00 PM
CEST
(237) Assessment of Surgical Antibiotic Prophylaxis Appropriateness in Obstetrics and Gynaecological Surgery in Kuwait: A National Point Prevalence Survey
Favorite
8:00 AM – 6:00 PM
CEST
(238) Association between repeated antibiotic prescribing and hospitalization among people living with dementia: a population-based cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(239) Background Incidence Rates of Guillain-Barre Syndrome in United States Older Adults at Risk of Respiratory Syncytial Virus in a Trial-Similar Real World Data Cohort
Favorite
8:00 AM – 6:00 PM
CEST
(240) Ceftazidime-avibactam versus Colistin in the treatment of Carbapenem-Resistant Enterobacteriaceae infections
Favorite
8:00 AM – 6:00 PM
CEST
(241) Clinical manifestations, complications, and healthcare utilization of adult outpatients with RSV infection in the United States: a retrospective real-word study
Favorite
8:00 AM – 6:00 PM
CEST
(242) Clostridioides difficile Infection in South Korea: Retrospective Study on Annual Incidence Rates and Treatment Status
Favorite
8:00 AM – 6:00 PM
CEST
(243) Comorbidities and Numbers of Drugs Prescribed Influence the Potential Drug Interactions in Pulmonary Tuberculosis Patients in A Public Hospital in Banjarmasin, Indonesia
Favorite
8:00 AM – 6:00 PM
CEST
(244) Comparative Effect of Four Antimalarial Treatments on Haematocrit in Children in Southwest, Nigeria.
Favorite
8:00 AM – 6:00 PM
CEST
(245) Comparative Effectiveness of Single-Drug Versus Vancomycin-based Combination Antimicrobial Regimens in Post-Neurosurgical Infections at a Northwest China Hospital
Favorite
8:00 AM – 6:00 PM
CEST
(246) Comparative Postmarketing Safety Assessment of Baloxavir Marboxil vs Oseltamivir using TreeScan™
Favorite
8:00 AM – 6:00 PM
CEST
(247) DARWIN EU® - Characterization of Patients with Chronic Hepatitis B and C
Favorite
8:00 AM – 6:00 PM
CEST
(248) Data mining of adverse reactions of antimicrobial agents leading to coagulation disorders based on FAERS database
Favorite
8:00 AM – 6:00 PM
CEST
(249) Decreased risk of clinical gallstone disease after antibiotics that kill or inhibit 7α-dehydroxylating-bacteria
Favorite
8:00 AM – 6:00 PM
CEST
(250) Disparities In Direct-Acting Antiviral Agents Uptake And Mortality Among Patients With HCV-Related HCC
Favorite
8:00 AM – 6:00 PM
CEST
(251) Dynamic containment strategy in critical ill patients with high risk of antibiotic drug resistance, a MIMIC-IV study
Favorite
8:00 AM – 6:00 PM
CEST
(252) Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase 4 inhibitors on liver outcomes in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
Favorite
8:00 AM – 6:00 PM
CEST
(254) Enhancing US Lyme Disease Detection in Claims Data: Identifying Acute and Disseminated Disease
Favorite
8:00 AM – 6:00 PM
CEST
(255) Evaluating the Cardioprotective Effects of Antivirals in Influenza Patients: A Retrospective Cohort Study.
Favorite
8:00 AM – 6:00 PM
CEST
(256) Evaluation of Antimicrobial Stewardship Metrics in General Surgery Wards
Favorite
8:00 AM – 6:00 PM
CEST
(257) Evaluation of different ARIMA models incorporating the impact of COVID-19 for the forecasting of the prescription rates of antibiotics in the UK between 2013 to 2023
Favorite
8:00 AM – 6:00 PM
CEST
(258) Evaluation of the Vaccinated Concurrent Comparator Methodology for Near Real Time Safety Surveillance
Favorite
8:00 AM – 6:00 PM
CEST
(259) Exploring the Effects of COVID-19 on Antibiotic Consumption Patterns in Iran’s Outpatient Setting: A Cross-Sectional Study
Favorite
8:00 AM – 6:00 PM
CEST
(260) Fluoroquinolones and the risk of aortic aneurysm or dissection: a cohort study in German health claims data
Favorite
8:00 AM – 6:00 PM
CEST
(261) Framework for Public-Private Partnerships for Real-World Data Exchange of Immunizations Records for Public Health Surveillance
Favorite
8:00 AM – 6:00 PM
CEST
(262) Frequency and Duration of Antibiotic Shortages: A Global Comparison
Favorite
8:00 AM – 6:00 PM
CEST
(263) Human albumin for adults with sepsis: an updated systematic review and meta-analysis of randomized controlled trials
Favorite
8:00 AM – 6:00 PM
CEST
(264) Human papillomavirus vaccination among Adolescents and Young Adults who have been treated for cancer: a matched comparative cohort study from the French National Health Data System
Favorite
8:00 AM – 6:00 PM
CEST
(265) id.DRIVE: a Public-Private Partnership for Burden and Effectiveness Studies on Infectious Diseases, Vaccines, Related Preventive Measures and Therapeutics in Europe.
Favorite
8:00 AM – 6:00 PM
CEST
(266) Identifying Potential Drug Interactions in Kidney-Impaired Individuals Co-infected with Human Immunodeficiency Virus and Malaria in Lagos: A Focus for Enhancing Treatment Strategies.
Favorite
8:00 AM – 6:00 PM
CEST
(267) Impact of medication adherence to active tuberculosis occurrence in pediatric population with latent tuberculosis infection: A population-based cohort study in South Korea
Favorite
8:00 AM – 6:00 PM
CEST
(268) Impact of National Public-Private Mix and Medical Expense Support Program for Control Tuberculosis in South Korea: An Interrupted Time Series Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(269) Impact of Obesity on Clinical and Economic Outcomes in Hospitalized Patients with Skin and Subcutaneous Tissue Infections Receiving Systemic Antibacterial Therapy in Korea
Favorite
8:00 AM – 6:00 PM
CEST
(270) Knowledge Attitude and Practice of Obstetricians and Gynaecologists towards appropriate surgical antibiotic prophylaxis prescribing in Obstetric and gynaecological surgery in Kuwait: A national cross-sectional survey
Favorite
8:00 AM – 6:00 PM
CEST
(271) Knowledge, attitude, and practices of pharmacy students in seven Middle Eastern countries concerning antimicrobial resistance
Favorite
8:00 AM – 6:00 PM
CEST
(272) Liver Enzymes During and After Antimalarial Therapy with Artemether-Lumefantrine in Nigerian Children with Uncomplicated Plasmodium Falciparum Infection.
Favorite
8:00 AM – 6:00 PM
CEST
(273) Medicine use in children aged under 12 years in Serbia: a focus on antibiotics
Favorite
8:00 AM – 6:00 PM
CEST
(274) Oral Antibiotic Shortages and Their Impact on Drug Utilization in Australia
Favorite
8:00 AM – 6:00 PM
CEST
(275) Outpatient Use of Antibiotics in Iran: A National study using claim data from 2014 to 2019
Favorite
8:00 AM – 6:00 PM
CEST
(276) Over-the-counter sales of high-priority antibiotics is common: results of a global survey
Favorite
8:00 AM – 6:00 PM
CEST
(278) Patients’ Knowledge, Attitude, And Practices of Self-Medication with Antibiotics
Favorite
8:00 AM – 6:00 PM
CEST
(279) Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities
Favorite
8:00 AM – 6:00 PM
CEST
(280) Post-marketing surveillance for the safety of the 4-valent human papillomavirus (HPV) vaccine in China: a retrospective real-world study
Favorite
8:00 AM – 6:00 PM
CEST
(281) Prevalence and Patterns of Antibiotic Prophylaxis in Kuwaiti Obstetric and Gynaecological Surgery: A National Point Prevalence Survey
Favorite
8:00 AM – 6:00 PM
CEST
(282) Progress toward implementation of national antimicrobial resistance action plans, including use of the internet
Favorite
8:00 AM – 6:00 PM
CEST
(283) Recurrence of Diabetic Foot Complications: A Domino Effect Leading to Lethal Consequences - Insights from a National Longitudinal Study
Favorite
8:00 AM – 6:00 PM
CEST
(284) Retrospective Cross-Sectional Study Assessing Adverse Events And Treatment Failure In Pediatric Hemato-Oncological Patients Receiving Posaconazole (Off-label) Or Liposomal Amphotericin B Prophylaxis
Favorite
8:00 AM – 6:00 PM
CEST
(285) Risk Factors of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong – a Population-based Unmatched Case-control Study
Favorite
8:00 AM – 6:00 PM
CEST
(286) Safety of the Use of Fluoroquinolone Antibiotics in Patients with Kidney Disease
Favorite
8:00 AM – 6:00 PM
CEST
(287) Safety Results of Post-Marketing Surveillance Studies of B/F/TAF in China and South Korea
Favorite
8:00 AM – 6:00 PM
CEST
(288) Self-test as a strategy to promote HIV testing among men who have sex with men and transgender women - overview of systematic reviews and meta-analyses
Favorite
8:00 AM – 6:00 PM
CEST
(289) Serotype Distribution, Antibiotics Use, and Antimicrobial Resistance in Paediatric Patients with Pneumococcal Infection in Hong Kong – a Population-based Study
Favorite
8:00 AM – 6:00 PM
CEST
(290) The Effect of antibiotics prescription and length of hospitalization on mortality in patients with systemic infections
Favorite
8:00 AM – 6:00 PM
CEST
(291) The HAPPY PATIENT Project: Measuring and Improving Community Antibiotic Dispensing in Europe
Favorite
8:00 AM – 6:00 PM
CEST
(292) The role of Rheumatic Diseases in the relationship between mRNA vaccines and Myocarditis/Pericarditis in a cohort of Italian vaccinees: TheShinISS-Vax Study
Favorite
8:00 AM – 6:00 PM
CEST
(293) Time trends of prevalence of drugs with suggested shortages in Europe
Favorite
8:00 AM – 6:00 PM
CEST
(294) Urinary tract infection diagnosis and management in eight European countries: Results of a context analysis study.
Favorite
8:00 AM – 6:00 PM
CEST
(295) Use of antibacterials and suspected acute renal failure in Brazil: pharmacovigilance analysis, 2018-2023
Favorite
8:00 AM – 6:00 PM
CEST
(296) Use of Non-Specific Immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry
Favorite
8:00 AM – 6:00 PM
CEST
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(298) A nationwide study of psychotherapy treatment at Danish psychiatric clinics
Favorite
8:00 AM – 6:00 PM
CEST
(299) An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of paliperidone, risperidone, and low-energy fracture
Favorite
8:00 AM – 6:00 PM
CEST
(300) Antipsychotics in treatment of adolescents with schizophrenia in China
Favorite
8:00 AM – 6:00 PM
CEST
(301) Anxiety Disorders Diagnosed in Outpatient Encounters Among Commercially Insured US Adults
Favorite
8:00 AM – 6:00 PM
CEST
(302) Assessment of Polypharmacy And Potentially Inappropriate Medication Use Among Psychiatric Patients: A Prospective Study.
Favorite
8:00 AM – 6:00 PM
CEST
(303) Benzodiazepine receptor agonists and increased risk of sudden sensorineural hearing loss
Favorite
8:00 AM – 6:00 PM
CEST
(304) Brain derived Neurotrophic factor (BDNF): A potential biomarker for seizure associated cognitive impairment in adult persons with epilepsy (PWE)
Favorite
8:00 AM – 6:00 PM
CEST
(305) Daridorexant and sleeping disorders: comparative study with sleeping medication (zopiclone, oxazepam).
Favorite
8:00 AM – 6:00 PM
CEST
(306) Development of matching procedures to identify comparators for real-world comparative evaluations of antipsychotics
Favorite
8:00 AM – 6:00 PM
CEST
(307) Efficacy and safety of riluzole in the treatment of Amyotrophic Lateral Sclerosis, a population based study in Italy
Favorite
8:00 AM – 6:00 PM
CEST
(308) Evaluation Epilepsy Patterns and Treatment Approaches: Findings from a Neurological Tertiary Care Hospital
Favorite
8:00 AM – 6:00 PM
CEST
(309) Examining the impact of benzodiazepine formulary restrictions on benzodiazepine-related harms in a Medicaid population, 2004-2016
Favorite
8:00 AM – 6:00 PM
CEST
(310) Fatal intoxications with zopiclone and alprazolam in Sweden during 2012-2020 – a register-based study
Favorite
8:00 AM – 6:00 PM
CEST
(311) Generalized anxiety disorder: Epidemiology, burden, and comorbid depression.
Favorite
8:00 AM – 6:00 PM
CEST
(312) Identifying Longitudinal Medication Adherence Patterns of Antipsychotic Treatments; A Real-World Cohort Study in Catalonia, Spain.
Favorite
8:00 AM – 6:00 PM
CEST
(313) Influence of unemployment on antidepressant sales in drugstores in Brazil: time series analysis, 2014-2021
Favorite
8:00 AM – 6:00 PM
CEST
(314) Mapping the Epidemiological burden of active and lifetime epilepsy in Asian Countries: A Systematic review and Meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(315) Post-discharge Use of Antipsychotics in Patients with Hospital-acquired Delirium and Associated Risk of Mortality – A Target Trial Emulation Framework Study
Favorite
8:00 AM – 6:00 PM
CEST
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Favorite
8:00 AM – 6:00 PM
CEST
(317) Psychotropic medicine use in the German National Cohort (NAKO) baseline
Favorite
8:00 AM – 6:00 PM
CEST
(318) Safety and efficacy of second-generation antipsychotics in Autism Spectrum Disorder: a systematic review and network meta-analysis
Favorite
8:00 AM – 6:00 PM
CEST
(319) The risk of myocarditis, cardiomyopathy and cutaneous vasculitis associated with quetiapine in patients with schizophrenia and bipolar disorder.
Favorite
8:00 AM – 6:00 PM
CEST
(320) Therapeutic strategies after discontinuation of valproate in clinical practice in women with bipolar disorder: a cohort study in the United Kingdom and France databases
Favorite
8:00 AM – 6:00 PM
CEST
(321) Therapeutic strategies after discontinuation of valproate in clinical practice in women with epilepsy: a cohort study in the United Kingdom and France databases
Favorite
8:00 AM – 6:00 PM
CEST
(322) Trends in gabapentinoid prescribing: a nationwide Danish drug utilization study
Favorite
8:00 AM – 6:00 PM
CEST
(323) Trends In Psychotropic Medication Utilisation in Community Pharmacies In Chile Between 2018 - 2022
Favorite
8:00 AM – 6:00 PM
CEST
(324) Utilization of Antiparkinsonian Medication in Romania over 25 years
Favorite
8:00 AM – 6:00 PM
CEST
(325) Utilization of Psychotropic Medications Among Patients Diagnosed with Glioma: A Multinational Drug Utilisation Study
Favorite
8:00 AM – 6:00 PM
CEST
(326) Anti-epileptic Drugs Use and the Risk of Glaucoma: A population-Based Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(327) Characteristics of a population using anti-glaucoma therapy in the UK CPRD GOLD
Favorite
8:00 AM – 6:00 PM
CEST
(328) Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark – A observational registry study of 30,100 Danish patients with glaucoma
Favorite
8:00 AM – 6:00 PM
CEST
(329) Adverse Events of Drugs Used in Pain Therapies: An Analysis of Spontaneous Reports from Switzerland
Favorite
8:00 AM – 6:00 PM
CEST
(330) Analgesia Dispensing in Primary Care in Ireland and England - A Repeated Cross-Sectional Study
Favorite
8:00 AM – 6:00 PM
CEST
(331) Comparative risk of mortality in new users of prescription opioids for non-cancer pain: results from the International Pharmacosurveillence Study
Favorite
8:00 AM – 6:00 PM
CEST
(332) Antenatal depressive and anxiety symptoms in women with eating disorders who continue or discontinue antidepressant treatment in pregnancy - results from the Norwegian Mother, Father, and Child Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(333) Fatal intoxications with paracetamol in Sweden – a majority of fatalities had a prescription
Favorite
8:00 AM – 6:00 PM
CEST
(334) Impact of pharmacovigilance interventions targeting diclofenac on pain medication use in the United Kingdom
Favorite
8:00 AM – 6:00 PM
CEST
(335) Natural history of knee osteoarthritis with regards to other joint sites and knee replacement: a population-based cohort study in the UK Clinical Practice Research Datalink (CPRD)
Favorite
8:00 AM – 6:00 PM
CEST
(336) Prevalence and risk factors associated with adverse drug reactions to propofol used during interventional endoscopic procedures in a Peruvian population: cross-sectional study
Favorite
8:00 AM – 6:00 PM
CEST
(337) Prevalence, characteristics, and prescription pain medication use in the osteoarthritis population
Favorite
8:00 AM – 6:00 PM
CEST
(338) Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain
Favorite
8:00 AM – 6:00 PM
CEST
(339) Risk of lower extremity injury following concussion in the National Football League
Favorite
8:00 AM – 6:00 PM
CEST
(340) Self-reported physical functioning in patients with chronic low back pain (CLBP)
Favorite
8:00 AM – 6:00 PM
CEST
(341) Development and Evaluation of Python Language Processed Automated Disproportionality Analysis System for FAERS Database
Favorite
8:00 AM – 6:00 PM
CEST
(342) Exploration of Novel Adverse Drug Reactions of Trifluoperazine using FAERS database and Identification of Associated Genes and Proteins
Favorite
8:00 AM – 6:00 PM
CEST
(343) Identifying the Safety Signals for Adverse Events Causing Mortality Due to Ferric Carboxymaltose: A Disproportionality Analysis of Spontaneous Reports and Extensive Systematic Review
Favorite
8:00 AM – 6:00 PM
CEST
(344) Interpreting Vedolizumab: Uncovering Cachexia Signal in U.S Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Favorite
8:00 AM – 6:00 PM
CEST
(345) Medication Errors in EudraVigilance: Signals of Disproportionate Reporting Among Age Groups
Favorite
8:00 AM – 6:00 PM
CEST
(346) Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Favorite
8:00 AM – 6:00 PM
CEST
(347) Post-marketing safety of ALK inhibitors: an analysis of EudraVigilance reports between 2012 and 2022
Favorite
8:00 AM – 6:00 PM
CEST
(348) Recent Trends in Global Adverse Event Reporting: A Descriptive Analysis of VigiBase
Favorite
8:00 AM – 6:00 PM
CEST
(349) Safety Analysis of Adverse Drug Reactions in United States: A 21-Year descriptive Study of FDA Adverse Event Reporting System
Favorite
8:00 AM – 6:00 PM
CEST
(350) Transverse Myelitis Associated with Tozinameran Use: Adverse Events- Signal
Favorite
8:00 AM – 6:00 PM
CEST
(351) Unveiling the Hidden Toll of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.
Favorite
8:00 AM – 6:00 PM
CEST
(352) Views on The Development and Use of a New Digital Health Platform to Improve Adverse Drug Event Detection, Management and Reporting in Australia: A Qualitative Study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT01) Validity of the ICD-10-CM diagnosis code to identify patients with COVID-19 in Medicare administrative claims data
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT02) Contents of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT03) The Value of Large Population-based Electronic Health Record and Insurance Claims Databases for Real-World Evidence Generation in Rare Diseases: a Systematic Literature Review
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT04) Use of Fluoroquinolones and Risk of Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study Using Two National Representative Claims Data
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT06) Comorbidity associated with COVID-19 hospitalisation among 135,000 children and adolescents with SARS-CoV-2 infection during their initial COVID-19 vaccination campaign in Spain
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT07) Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT08) Towards a Framework to Describe Diversity of Real-World Data Sources: Findings from the DIVERSE Initiative
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT09) Development of a Machine Learning Prediction Model for COVID-19 Patient Outcome Using a Sequential Data-Based Patient Similarity Metric
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT10) Evaluation of drug hypersensitivity reactions documented in a new coded and structured hypersensitivity documentation tool with de-labeling function: A retrospective cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT11) Evaluation of ablation workflow for Paroxysmal and Persistent Atrial Fibrillation Treatment using electronic health record linked with digital health data
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT12) External validation using real world data of a generative AI assisted medication-indication knowledge base
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT13) Patient Engagement and Adherence to Digital Tasks: WEARable Activity Tracker Study Exploring Rheumatoid Arthritis Patients’ Disease Activity using Patient-Reported Outcome Measures, Clinical Measures, and Biometric Sensor Data
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT14) Drug Burden Index is a Strong Modifiable Predictor of 30-Day Hospitalisation in Community-Dwelling Older Adults: Machine Learning Analysis of InterRAI Data.
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT15) Automation of study report abstract generation by Large Language Models, methodology and application example
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT16) Machine Learning Applications for Predicting Empirical Antibiotic Treatment Failure in Urinary Tract Infections
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT17) Trends in concomitant prescribing of anticoagulants and antiseizure medications among people with stroke in the United Kingdom.
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT18) Antidepressant long-term and potential high-risk prescribing in two Scottish health boards: a cross-sectional analysis
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT19) How many people would be eligible for treatment with nasal esketamine in Denmark? A critical assessment of the definition of treatment-resistant depression
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT20) Population-level utilization of direct-acting antiviral agents and trends in hepatitis C related hospitalizations
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT21) Global trends in outpatient gabapentinoid utilization: A cross‐sectional analysis of 67 countries
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT22) Psychotropic medication use in Australian aged care before and after aged care reforms, 2018 and 2022
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT23) Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-based Study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT24) Cardiovascular Medicine Use in Adults with ADHD: A Nationwide Study in Australia
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT25) Drug-Drug Interactions Between Direct-Acting Oral Anticoagulants and Antiseizure Medications: A Target Trial Emulation
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT26) Effect of drug-drug interactions involving direct-acting oral anticoagulants and statins on the risk of bleeding
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT27) Risk of thyroid dysfunction associated with the concomitant use of amiodarone and sulfonylureas: a nationwide cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT28) The Economic Burden of Drug-Drug Interactions in an Older Population acutely admitted to Hospital in Ireland: A Propensity Score Pharmacoeconomic Analysis.
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT29) Drug-Drug Interactions in the Older Community-Dwelling Population: Findings from The Irish LongituDinal study on Ageing
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT30) The prevalent new-user design to study drug-drug interactions: the example of sulfonylureas and warfarin interaction on the risk of severe hypoglycemia
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT31) Trends in the Concurrent Use of Illicit Drugs and Interacting Prescription Medications Among Adults in the United States
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT32) Concomitant use of direct oral anticoagulants and pharmacokinetically-interacting antiarrhythmics and the risk of major bleeding in patients with non-valvular atrial fibrillation: population-based cohort study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT33) Antimicrobial Resistance Patterns of Escherichia coli urine isolates in the greater Sydney community from 2008 to 2018: a Geospatial Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT34) Climate vulnerability and utilization of electricity-dependent durable medical equipment among Medicare beneficiaries in North Carolina
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT35) Geographical visualization of Antibiotic use and Escherichia coli Antibiotic resistance Patterns in the greater Sydney community from 2016 to 2018
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT36) A Data-driven Approach to Unravelling the Contextual Social Determinants of Racial/Ethnic Health Disparities in Nonadherence to Antihypertensive Medications
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT37) Climate Impact of Intravenous versus Oral Antibiotics: A Comparative Waste Assessment
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT38) Endocrine disrupting chemicals associated health hazards from polyethylene terephthalates used in edible packaging: A Systematic review of clinical studies
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT39) Antimicrobial Resistance of Escherichia coli and Anti-diabetics: A Multi-year Geospatial Analysis
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT40) Evaluating the intersection of climate vulnerability and cancer burden in North Carolina
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT41) Clinical and Adverse Outcomes Associated with Concomitant Use of CYP2D6-metabolized Opioids with Antidepressants in Older Nursing Home Residents—A Retrospective Cohort Study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT42) Antiseizure Medications Use And the Risk Of Parkinson’s Disease: A 15-year Population-based Study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT43) Fall risk increasing adverse reactions (FRIARs) and fracture risk: A nested case control study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT44) De-Med: Developing a Tool for Identifying and Categorizing Potentially Inappropriate Medications in the Elderly Using Beers Criteria, STOPP, and FORTA - A Cross-Sectional Study
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT45) Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT46) Comparative Effectiveness of Short Acting Opioid Escalation and Initiation of a Long-Acting Opioid in Nursing Home Residents
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT47) Utilization of Benzodiazepines in the U.S.: An Analysis of Medical Expenditure Panel Survey
Favorite
8:00 AM – 6:00 PM
CEST
(ASPOT48) Discontinuation of preventative treatments in older people with complex health needs: self-controlled case series analyses of preventable cardiovascular events
Favorite
